A Review of Brain Stimulation Treatments for Late-Life Depression

Current Treatment Options in Psychiatry

Volumn 2, Issue 4, 2015, Pages 413-421

  Blumberger, Daniel M ^a,b   Hsu, Jonathan H ^b   Daskalakis, Zafiris J ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain stimulation; Deep brain stimulation; Electroconvulsive therapy; Geriatric depression; Late life depression; Magnetic seizure therapy; Neuromodulation; Repetitive transcranial magnetic simulation; Transcranial direct current stimulation; Vagus nerve stimulation

Indexed keywords

EID: 85007538259     PISSN: None     EISSN: 21963061     Source Type: Journal    
DOI: 10.1007/s40501-015-0059-0     Document Type: Review

References (76)

1. Husain MM, Rush AJ, Sackeim HA, et al. Age-related characteristics of depression: a preliminary STAR*D Report. Am J Geriatr Psychiatr. 2005;13(10):852–60.
2. Bruce ML, Ten Have TR, Reynolds 3rd CF, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291(9):1081–91.
3. Turvey CL, Conwell Y, Jones MP, et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatr. 2002;10(4):398–406.
4. World Health Organization. Mental health and older adults. 2013.
5. Belanger A, Martel L. Caron-Malenfant r, Statistics Canada. Demography Division. Population projections for Canada, provinces and territories, 2005-2031. Ottawa: Statistics Canada, Demography Division; 2005.
6. Mulsant BH, Pollock BG. Treatment-resistant depression in late life. J Geriatr Psychiatry Neurol. 1998;11(4):186–93.
7. Thase M, Rush A. Treatment resistant depression. New York: Raven Press Ltd.; 1995.
8. Rush JA, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry. 2006;163(11):1905–17.
9. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin N Am. 1996;19(2):179–200.
10. Baldwin RC. Refractory depression in late life: a review of treatment options. Rev Clin Gerontol. 1996;6(4):343–8.
11. Mulsant BH, Houck PR, Gildengers AG, et al. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? J Clin Psychopharmacol. 2006;26(2):113–20.
12. Reynolds 3rd CF, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354(11):1130–8.
13. Tew JD, Mulsant BH, Houck PR, et al. Impact of prior treatment exposure on response to antidepressant treatment in late life. Am J Geriatr Psychiatr. 2006;14(11):957–65.
14. Blazer DG. The prevalence of depressive symptoms. J Gerontol A Biol Sci Med Sci. 2002;57(3):M150–1.
15. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003;289(23):3152–60.
16. Doraiswamy PM, Khan ZM, Donahue RMJ, Richard NE. Quality of life in geriatric depression - a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatr. 2001;9(4):423–8.
17. Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol. 2005;45(10):1106–22.
18. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med. 2007;357(19):1939–45.
19. Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196(3):226–34.
20. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66(7):729–37.
21. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2006;32(1):244–54.
22. American Psychiatric Association Committee on Electroconvulsive T. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC: American Psychiatric Association. 2001.
23. Stek M, Hoogendijk W, Beekman A. Electroconvulsive therapy for the depressed elderly. The Cochrane Library 2003
24. Spaans H-P, Sienaert P, Bouckaert F, et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry. 2015;206(1):67–71. This is an important secondary analysis demonstrating the superiority in speed of remission with ECT compared to pharmacotherapy.
25. Spaans H-P, Verwijk E, Comijs HC, et al. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study. J Clin Psychiatr. 2013;74(11):e1029–36.
26. Kok R, Nolen W, Heeren T. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. Int J Geriatr Psychiatr. 2007;22(12):1247–54.
27. Kellner CH, Geduldig ET, Knapp RG, et al. More data on speed of remission with ECT in geriatric depression. Br J Psychiatry. 2015;206(2):167.
28. Prudic J, Haskett RF, McCall WV, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT. 2013;29(1):3–12. Despite the high remission with ECT this study showed high relapse rates with aggressive augmentation pharmacotherapy with lithium.
29. Manepalli J, Sapkota N. Neuromodulation therapies in the elderly depressed patient. Curr Geriatr Rep. 2014;3(4):229–36.
30. Figiel GS, Epstein C, McDonald WM, et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J Neuropsychiatry Clin Neurosci. 1998;10(1):20–5.
31. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9(6):641–54.
32. Manes F, Jorge R, Morcuende M, et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int Psychogeriatr. 2001;13(2):225–31.
33. Mosimann UP, Marre SC, Werlen S, et al. Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Arch Gen Psychiatry. 2002;59(6):560–1.
34. Mosimann UP, Schmitt W, Greenberg BD, et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 2004;126(2):123–33.
35. Kozel FA, Nahas Z, deBrux C. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci. 2000;12(3):376–84.
36. Nahas Z, Li X, Kozel FA, et al. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004;19(4):249–56.
37. Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2008;65(3):268–76.
38. Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med. 2014;44(2):225–39.
39. Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116(3):165–73.
40. Blumberger DM, Mulsant BH, Fitzgerald PB, et al. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression. World J Biol Psychiatry. 2012;13(6):423–35. Adults over age 60 were included in this study and seem to respond better with sequential bilateral rTMS using 120% of the motor threshold.
41. Levkovitz Y, Harel EV, Roth Y, et al. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul. 2009;2(4):188–200.
42. Deng Z-D, Lisanby SH, Peterchev AV. Electric field strength and focality in electroconvulsive therapy and magnetic seizure therapy: a finite element simulation study. J Neural Eng. 2011;8(1):016007.
43. Lisanby SH. Update on magnetic seizure therapy: a novel form of convulsive therapy. J ECT. 2002;18(4):182–8.
44. Luber B, Nobler MS, Moeller JR, et al. Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. J ECT. 2000;16(3):229–43.
45. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ECT. Am J Psychiatr. 2001;158(2):305–8.
46. McClintock SM, Tirmizi O, Chansard M, Husain MM. A systematic review of the neurocognitive effects of magnetic seizure therapy. Int Rev Psychiatr. 2011;23(5):413–23.
47. Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45(5):569–76.
48. Fitzgerald PB, Hoy KE, Herring SE, et al. Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder. Depression Anxiety. 2013;30(2):129–36.
49. Hoy KE, Thomson RH, Cherk M, et al. Effect of magnetic seizure therapy on regional brain glucose metabolism in major depression. Psychiatry Res. 2013;211(2):169–75.
50. Noda Y, Daskalakis ZJ, Fitzgerald PB, et al. Magnetic seizure therapy-induced mania: a report of 2 cases. J ECT. 2015;31(1):e4–6.
51. Devanand DP, Sackeim HA, Decina P, Prudic J. The development of mania and organic euphoria during ECT. J Clin Psychiatry. 1988;49(2):69–71.
52. Lee J, Arcand L, Narang P, Lippmann S. ECT-induced mania. Innov Clin Neurosci. 2014;11(11-12):27–9.
53. Fritsch B, Reis J, Martinowich K, et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 2010;66(2):198–204.
54. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000;527(Pt 3):633–9.
55. Zheng X, Alsop DC, Schlaug G. Effects of transcranial direct current stimulation (tDCS) on human regional cerebral blood flow. Neuroimage. 2011;58(1):26–33.
56. Costain R, Redfearn JW, Lippold OC. A controlled trial of the therapeutic effect of polarization of the brain in depressive illness. Br J Psychiatr J Ment Sci. 1964;110:786–99.
57. Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychological medicine 2012:1-10
58. Boggio PS, Rigonatti SP, Ribeiro RB, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol Off Sci Journal Coll Int Neuropsychopharmacologicum. 2008;11(2):249–54.
59. Fregni F, Boggio PS, Nitsche MA, et al. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord. 2006;8(2):203–4.
60. Fregni F, Boggio PS, Nitsche MA, et al. Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression. Depress Anxiety. 2006;23(8):482–4.
61. Loo CK, Alonzo A, Martin D, et al. Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. Br J Psychiatr J Ment Sci. 2012;200(1):52–9.
62. Loo CK, Sachdev P, Martin D, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol Off Sci J Coll Int Neuropsychopharmacologicum. 2010;13(1):61–9.
63. Palm U, Schiller C, Fintescu Z, et al. Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study. Brain Stimul. 2012;5(3):242–51.
64. Blumberger DM, Tran LC, Fitzgerald PB, et al. A randomized double-blind sham-controlled study of transcranial direct current stimulation for treatment-resistant major depression. Front Psychiatr Front Res Found. 2012;3:74.
65. Brunoni AR, Valiengo L, Baccaro A et al. The Sertraline vs Electrical Current Therapy for Treating Depression Clinical Study: Results From a Factorial, Randomized, Controlled Trial. JAMA psychiatry 2013:1-9
66. Marquez J, van Vliet P, McElduff P, et al. Transcranial direct current stimulation (tDCS): does it have merit in stroke rehabilitation? A systematic review. Int J Stroke. 2015;10(3):306–16.
67. Berry SM, Broglio K, Bunker M, et al. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices. 2013;6:17–35.
68. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005;58(5):347–54.
69. Sirven JI, Sperling M, Naritoku D, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology. 2000;54(5):1179–82.
70. Merrill CA, Jonsson MA, Minthon L, et al. Vagus nerve stimulation in patients with Alzheimer’s disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry. 2006;67(8):1171–8.
71. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651–60.
72. Lakhan SE, Callaway E. Deep brain stimulation for obsessive-compulsive disorder and treatment-resistant depression: systematic review. BMC Res Notes. 2010;3:60.
73. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69(2):150–8.
74. Ramasubbu R, Anderson S, Haffenden A, et al. Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. J Psychiatry Neurosci. 2013;38(5):325–32.
75. Dougherty DD RA, Carpenter LL, Howland RH, Bhati MT, O’Reardon JP, Eskandar EN, et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol Psychiatry. 2014. doi:10.1016/j.biopsych.2014.11.023.
76. Galvez JF, Keser Z, Mwangi B, et al. The medial forebrain bundle as a deep brain stimulation target for treatment resistant depression: A review of published data. Prog Neuropsychopharmacol Biol Psychiatry. 2015;58:59–70.